02696.HK
Shanghai Henlius Biotech, Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 49.06
−1.72%Margins
Gross margin
74.7%
EBITDA margin
17.1%
EBIT margin
12.1%
Net margin
11.7%
FCF margin
8.6%
19.1%
Return on equity
6.6%
Return on assets
10.6%
Return on invested capital
0.57x
Asset turnover
HKD 957.7M
Cash from operations
HKD 2.07
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026